She wakes before dawn, packs lunches, manages households, holds careers together, and still finds time to ask everyone else, "Are you okay?" The Indian woman is, in every sense, the backbone of her family. And yet, in giving so much of herself to others, she often becomes the last person she takes care of.

This International Women's Day, that needs to change.

Cancer remains one of the gravest health threats facing Indian women today.

Breast cancer has become the most frequently diagnosed cancer among Indian women — and unlike in Western countries, it is striking women in their 30s and 40s, at the very peak of their lives.

Cervical cancer, though almost entirely preventable, continues to claim thousands of lives every year — not because medicine has failed, but because awareness has.

Ovarian cancer, often called the "silent killer," is frequently caught only at advanced stages, making early vigilance all the more critical.

Thyroid cancer is emerging as a cancer that disproportionately affects women — occurring nearly three times more often in women than men. The good news is that it is also one of the most treatable cancers when detected early.

Women who notice a lump or swelling in the neck, unexplained hoarseness, or difficulty swallowing should not dismiss these signs.

A simple ultrasound and blood test can go a long way in ruling out — or catching — a problem early. The truth, however, is not bleak — it is urgent.

Early Detection Saves Lives

Most cancers, when found at an early stage, are highly treatable. Women above 40 should schedule regular clinical breast examinations and mammography.

Cervical cancer screening through a Pap smear or HPV test, starting as early as age 25–30, can detect precancerous changes before they ever become cancer. These tests are quick, safe, and available — what they need most is for women to simply show up.

Prevention, too, begins with everyday choices. Avoiding tobacco in all its forms — cigarettes, gutka, paan — is the single most powerful step. Regular physical activity, a diet rich in fruits and vegetables, maintaining a healthy weight, limiting alcohol, and getting the "HPV vaccine" (ideally between ages 9 and 14) can dramatically reduce cancer risk.

And perhaps just as importantly: listen to your body. An unusual lump, unexplained bleeding, or a symptom that won't go away is not something to push aside for later. Later can cost everything.

A healthy woman builds a healthy family — and a healthy nation. This Women's Day, let's give every woman around us the most meaningful gift possible: the reminder that her health is not selfish, it is essential.

Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic and Mounjaro, are best known for treating type 2 diabetes and obesity. However, a new study published in The BMJ suggests that people with diabetes using these blockbuster drugs may have an increased risk of hair loss (alopecia).

While the absolute risk is low, researchers from the University of Pennsylvania and the University of Southern California identified alopecia as a possible side effect of GLP-1 receptor agonists, particularly semaglutide and tirzepatide.

“GLP-1 receptor agonist use was associated with a higher risk of clinically recorded alopecia, particularly non-scarring alopecia, in patients with type 2 diabetes, compared with SGLT-2 and DPP-4 inhibitors,” the researchers wrote.

Non-scarring alopecia is a type of hair loss in which the hair follicles remain intact, making hair regrowth possible.

The researchers said the findings could help inform shared decision-making when considering GLP-1 receptor agonist therapy and highlight the need for further research into dermatological outcomes.

What Did The Study Find?

Researchers analyzed health data from 12,004 patients using GLP-1 receptor agonists and compared them with 15,221 patients using SGLT-2 inhibitors between January 2019 and September 2024. They also compared another 11,964 GLP-1 receptor agonist users with 11,233 DPP-4 inhibitor users.

The study found that adults using GLP-1 receptor agonists had:

• A 37% higher risk of alopecia than SGLT-2 inhibitor users (6.91 vs. 5.04 per 1,000 person-years).
• A 68% higher risk of alopecia than DPP-4 inhibitor users (6.53 vs. 3.89 per 1,000 person-years).

Further analyses showed the association was specific to non-scarring alopecia, with a 53% higher risk compared with SGLT-2 inhibitors and a 72% higher risk compared with DPP-4 inhibitors.

Why GLP-1 Drugs Are Linked to Hair Loss?

The researchers noted that rapid weight loss is a well-established trigger of hair shedding and may also lead to iron or zinc deficiencies, disrupting the hair growth cycle.

They added that hormonal changes may also play a role, although further studies are needed to understand the underlying mechanisms.

What Are the Study's Limitations?

The researchers acknowledged that they could not assess the severity, extent, duration, or reversibility of alopecia after treatment was stopped because of limited clinical information. They also could not rule out the influence of other unmeasured factors.

However, they said the study was based on high-quality data from a large, representative cohort, and the findings remained consistent across additional analyses.

“Our findings extend previous anecdotal safety signals and provide more systematic evidence to inform clinical awareness of this potential adverse effect,” the researchers concluded.

What To Do If You're Losing Hair on Ozempic, Mounjaro?

If you're experiencing excessive hair shedding while taking semaglutide, you may consider:

• Discussing with your physician whether your dosage should be adjusted or whether nutritional supplements may help.
• Increasing your protein intake to at least 100 grams per day.
• Taking hair-supporting nutrients such as biotin, vitamin D, iron, and zinc.
• Using topical treatments such as minoxidil to support hair regrowth.
• Avoiding severe calorie restriction and maintaining a nutritionally balanced diet.

Between climbing the career ladder, raising kids, and keeping everything else running smoothly, there's rarely a spare moment when women should stop and check in with their own bodies.

Yet these same demanding years are often when certain autoimmune and chronic conditions first start to surface. The early signs tend to be so mild and easy to explain away that most women simply put them down to stress, lack of sleep, or an overly full plate.

Some of the autoimmune conditions that commonly fly under the radar include:

· Lupus

· Rheumatoid arthritis

· Sjogren’s syndrome

· Systemic sclerosis

· Psoriatic arthritis

Family history matters more than most women realize. Autoimmune conditions often have a genetic component, and having a parent, sibling, or close relative with an autoimmune disorder meaningfully raises the likelihood of developing one yourself, even if the specific condition isn't identical. If this applies to a woman, the symptoms below deserve even closer attention and a lower threshold for seeking medical advice, rather than waiting to see if they resolve on their own.

So, when should women get it checked? If any of these symptoms stick around rather than passing after a good night's sleep, it's worth paying attention:

· Fatigue that doesn't go away no matter how much rest you get

· Joint pain or stiffness, especially in the morning

· Unexplained aches in your muscles

· Skin rashes or a new sensitivity to sunlight

· Sudden shifts in your weight or energy levels

It is advised not to dismiss them, particularly if they've been going on for a few weeks. Early detection changes everything. It is observed that the difference between a manageable condition and a complicated one often comes down to how soon it was caught.

Diagnose early, and treatment can be initiated before the disease has a chance to progress, allowing a patient to continue living life on her own terms, not one dictated by illness.

That said, the fundamentals of good health have never changed, and we continue to emphasize routine check-ups, a balanced diet, adequate sleep, regular physical activity, and sound stress management. But if there is one thing every woman should take seriously, it is to learn to listen to your own body.

You know it better than anyone else. If something feels different, do not dismiss it or wait it out; seek an opinion. Awareness combined with timely action is what ultimately allows a woman to lead a full, active life both professionally and personally, well into her later years.

(Dr. Chirag Rajkumar Kopp, Consultant - Rheumatology & Clinical Immunology, Ramaiah Memorial Hospital, Bengaluru)

In June, X-Men actor and former professional wrestler Tyler Mane revealed that he had been diagnosed with a "super-rare" form of breast cancer. The disease is uncommon in men, accounting for only about 1% of all breast cancer cases.

Now, as he undergoes treatment, the actor is encouraging men to pay attention to their health, have open conversations about family medical history, and never ignore unusual symptoms.

A Lump That Changed Everything

As he lost weight, he noticed a lump in his breast. Initially, he did not think it was serious and had it removed. However, laboratory tests revealed it was invasive ductal carcinoma, the most common form of breast cancer.

Following the diagnosis, Mane underwent genetic testing, where he found that he carries the BRCA2 gene mutation. The mutation significantly increases the risk of developing several cancers, including breast, prostate, pancreatic and, in women, ovarian cancer.

The discovery also made him realize how little he had discussed health issues with the men in his family.

Also read: Could Chemotherapy Soon Be Optional? AstraZeneca and Gilead Drugs Show Promise for Breast Cancer Patients

Mane Had Breast Cancer Stage 1

Although the cancer was caught early, doctors determined it was aggressive enough to require chemotherapy after surgery.

"I was lucky enough that my breast cancer was stage 1. Men usually don't notice the signs or don't quickly treat breast cancer. By the time it's diagnosed, it is often stage 3 or 4, metastasized throughout their bodies, and then it becomes a whole different thing," he wrote in an interview with Yahoo.

Mane explained that the tumor measured 28 millimeters and had a surgical margin of less than one millimeter, making additional treatment like chemotherapy and radiation necessary.

The actor added that genomic testing showed a high risk of recurrence without treatment.

'Chemotherapy Is Not Fun'

Mane is currently undergoing four rounds of chemotherapy followed by localized radiation therapy.

"I'm being treated with four rounds of chemo, and then I have to have some localized radiation treatment to make sure the cancer is all wiped out."

While treatment has been challenging, he said it is essential. "And let me tell you: Chemotherapy is not fun. But it is a necessity."

He also describing its side effects such as 'metal taste' hair loss and fatigue.

"They give you some really good steroids for the day before, the day of and the day after chemotherapy. But then when that wears off, it all kind of hits you. You get the metal taste in your mouth. You feel sluggish and want to sleep all the time. My beard fell out. I look like a hairless cat with a couple of tufts on my face now".

Learning To Slow Down During Treatment

The actor admitted he initially underestimated the impact chemotherapy would have on his body. He also realized he had pushed himself too hard physically in an effort to stay strong.

Now, he is focusing on maintaining his strength by increasing his protein intake while continuing moderate exercise.

"Physically, I'm trying to keep up my protein intake to help me stay strong throughout treatment."

Despite the challenges, Mane has continued a daily workout routine that includes push-ups, squats and rebounding exercises.

Message For Men

Through his public updates and the podcast Mane hopes to raise awareness that breast cancer is not exclusively a women's disease. By sharing his experience, he wants more men to recognize the symptoms early, discuss their family medical history, and seek medical attention without delay.